Featured Research

from universities, journals, and other organizations

Key molecule for keeping other oral microorganisms in check uncovered

Date:
September 26, 2010
Source:
University of Oklahoma
Summary:
A research team has uncovered a key to arresting the growth of thrush -- a type of oral yeast infection that sickens patients with compromised immune systems, diabetes and newborns as well as healthy individuals, who may contract the disease following antibiotic treatment of an illness.

A University of Oklahoma research team has uncovered a key to arresting the growth of thrush -- a type of oral yeast infection that sickens patients with compromised immune systems, diabetes and newborns as well as healthy individuals, who may contract the disease following antibiotic treatment of an illness.

An OU team of natural products chemists and microbiologists observed several clinical strains of Streptococcus mutans capable of arresting the growth of the pathogenic yeast Candida albicans. The bacteria species, S. mutans keeps other oral microorganisms in check by producing a chemical called mutanobactin A, which suppresses the growth of pathogenic microbes before they cause problems for humans.

Further tests are underway to evaluate the use of mutanobactin A as a drug for the treatment of thrush and related Candida infections. This compound may hold the key to understanding how microorganisms live cooperatively inside a human host. Also, these findings could provide clues to how the body's native microflora use naturally-occurring compounds to combat the invasion and spread of potentially pathogenic microbes.

These microbes strike an amazing balance between enhancing human health and causing devastating disease. Chemicals like mutanobactin A will help doctors carefully control microbial pathogens while preserving the integrity of important symbiotic organisms. This could lead to new and better drugs for treating infections and provide antibiotics that are less susceptible to the development of resistance.

Research was performed by Robert H. Cichewicz and P. Matthew Joyner, OU Department of Chemistry and Biochemistry Natural Products Discovery Group; Cichewicz also represents the OU Ecology and Evolutionary Biology Graduate Program; and Felicia Qi, Jinman Liu, Zhijun Zhang and Justin Merritt, OU Health Sciences Center College of Dentistry.

Ultimately, the study of microbial chemical communication systems such as mutanobactin A will improve the way doctors fight disease and help maintain human well-being. Findings from this study were published in the online edition of the September 17 issue of the journal Organic and Biomolecular Chemistry.


Story Source:

The above story is based on materials provided by University of Oklahoma. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Matthew Joyner, Jinman Liu, Zhijun Zhang, Justin Merritt, Fengxia Qi, Robert H. Cichewicz. Mutanobactin A from the human oral pathogen Streptococcus mutans is a cross-kingdom regulator of the yeast-mycelium transition. Organic & Biomolecular Chemistry, 2010; DOI: 10.1039/C0OB00579G

Cite This Page:

University of Oklahoma. "Key molecule for keeping other oral microorganisms in check uncovered." ScienceDaily. ScienceDaily, 26 September 2010. <www.sciencedaily.com/releases/2010/09/100924095826.htm>.
University of Oklahoma. (2010, September 26). Key molecule for keeping other oral microorganisms in check uncovered. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/09/100924095826.htm
University of Oklahoma. "Key molecule for keeping other oral microorganisms in check uncovered." ScienceDaily. www.sciencedaily.com/releases/2010/09/100924095826.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins